← United States · Coverage record
US · SEC FORM 4
Jazz Pharmaceuticals plc
JAZZ · Nasdaq · CIK 0001232524 · Healthcare · Biotechnology
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
71 Form 4 transaction lines observed in the same window
21 sales · 50 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 11 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-05-12 · Mulligan Seamus.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 5,479,715
- Previous report
- 4,676,811
- Avg daily volume
- 845,809
- Days to cover
- 6.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-05-12 | Mulligan Seamus | Purchase (P) | Ordinary Shares | 1,621 | USD 103.00 | USD 166,963 | SEC filing ↗ |
| 2025-05-09 | Mulligan Seamus | Purchase (P) | Ordinary Shares | 100,000 | USD 98.26 | USD 9,825,726 | SEC filing ↗ |
| 2024-03-01 | Johnson Philip L | Purchase (P) | Ordinary Shares | 12,000 | USD 119.65 | USD 1,435,800 | SEC filing ↗ |
| 2020-05-27 | Mulligan Seamus | Purchase (P) | Ordinary Shares | 35,000 | USD 111.26 | USD 3,894,061 | SEC filing ↗ |
| 2020-05-26 | Mulligan Seamus | Purchase (P) | Ordinary Shares | 15,000 | USD 110.65 | USD 1,659,750 | SEC filing ↗ |
Form 4 evidence
151 transaction lines in the latest 365-day window; 689 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | GALA RENEE D | Sale (S) | Ordinary Shares | 2,000 | USD 236.40 | USD 472,800 | SEC filing ↗ |
| 2026-10-01 | COZADD BRUCE C | Sale (S) | Ordinary Shares | 6,000 | USD 230.33 | USD 1,381,980 | SEC filing ↗ |
| 2026-09-10 | Patil Neena M | Sale (S) | Ordinary Shares | 1,200 | USD 240.94 | USD 289,128 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-10-06 | GALA RENEE D | Sale (S) | Ordinary Shares | 2,000 | USD 236.40 | USD 472,800 | SEC filing ↗ |
| 2026-10-01 | COZADD BRUCE C | Sale (S) | Ordinary Shares | 6,000 | USD 230.33 | USD 1,381,980 | SEC filing ↗ |
| 2026-09-10 | Patil Neena M | Sale (S) | Ordinary Shares | 1,200 | USD 240.94 | USD 289,128 | SEC filing ↗ |
| 2026-09-08 | Henderson Mary Elizabeth | Tax withholding (F) | Ordinary Shares | 1,427 | USD 243.01 | USD 346,776 | SEC filing ↗ |
| 2026-09-08 | GALA RENEE D | Sale (S) | Ordinary Shares | 2,000 | USD 243.03 | USD 486,060 | SEC filing ↗ |
| 2026-09-08 | GALA RENEE D | Tax withholding (F) | Ordinary Shares | 1,967 | USD 246.81 | USD 485,475 | SEC filing ↗ |
| 2026-09-01 | COZADD BRUCE C | Sale (S) | Ordinary Shares | 6,000 | USD 250.13 | USD 1,500,780 | SEC filing ↗ |
| 2026-08-31 | Winningham Rick E | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC filing ↗ |
| 2026-08-31 | Smith Mark Douglas | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC filing ↗ |
| 2026-08-31 | RIEDEL NORBERT G | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC filing ↗ |
| 2026-08-31 | McSharry Heather Ann | Tax withholding (F) | Ordinary Shares | 1,855 | USD 241.42 | USD 447,827 | SEC filing ↗ |
| 2026-08-31 | LOVE TED W | Tax withholding (F) | Ordinary Shares | 743 | USD 241.41 | USD 179,369 | SEC filing ↗ |
| 2026-08-31 | Kennedy Patrick | Tax withholding (F) | Ordinary Shares | 1,855 | USD 241.41 | USD 447,818 | SEC filing ↗ |
| 2026-08-31 | Henderson Mary Elizabeth | Tax withholding (F) | Ordinary Shares | 2,092 | USD 241.41 | USD 505,040 | SEC filing ↗ |
| 2026-08-31 | Hamill Laura | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.41 | USD 411,849 | SEC filing ↗ |
| 2026-08-31 | ENRIGHT PATRICK G | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.42 | USD 411,857 | SEC filing ↗ |
| 2026-08-31 | Cook Jennifer E. | Tax withholding (F) | Ordinary Shares | 1,706 | USD 241.41 | USD 411,849 | SEC filing ↗ |
| 2026-08-31 | COZADD BRUCE C | Tax withholding (F) | Ordinary Shares | 1,219 | USD 241.41 | USD 294,281 | SEC filing ↗ |
| 2026-08-27 | Iannone Robert | Sale (S) | Ordinary Shares | 76,921 | USD 249.70 | USD 19,207,166 | SEC filing ↗ |
| 2026-08-27 | Iannone Robert | Option exercise / conversion (M) | Ordinary Shares | 57,500 | USD 125.84 | USD 7,235,860 | SEC filing ↗ |
| 2026-08-05 | Winningham Rick E | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | Smith Mark Douglas | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | RIEDEL NORBERT G | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | Pearce Samantha | Tax withholding (F) | Ordinary Shares | 780 | USD 261.62 | USD 204,064 | SEC filing ↗ |
| 2026-08-05 | Mulligan Seamus | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | McSharry Heather Ann | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | LOVE TED W | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | Kennedy Patrick | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | Hamill Laura | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-08-05 | ENRIGHT PATRICK G | Award / grant (A) | Ordinary Shares | 1,605 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | JAZZ |
| CIK | 0001232524 |
| Sector | Healthcare |
| Industry | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 689 transaction lines from 2020-01-02 to 2026-10-06 10 P purchase lines · 306 S sale lines · 373 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.